The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
No problem at all Dibs. Good luck with your research. :)
We should know on or before the first half of December whether getting the expedited review. When apply for fast track the FDA normally give an answer within 60 days. This is when we will know if it will be May or whether it will be around August. Yes it looks like it is going to change pulmonary scanning across the globe. This is a gem that is beginning to be unearthed by the market.
No problem at all Dibs. Any time. I take it you know that FDA submission has taken place and have applied for Expedited review? If successful also applied for Hatch Waxman exclusivity so all going well should be looking at approval in May. I would defo always encourage DYOR.
Here is a brief overiew of Polx
Jonathan Allis (Non Executive Chairman) has succesfully been through the FDA approval process with his company Blue Earth which he then sold on to Bracco for $450 million dollars. The market for Polarizers is huge in comparison.
Bracco a major global diagnostics company are invested in Polarean and Cyrill Petit who is Chief Corporate Development Officer and Head of Strategic Initiatives of the Bracco Group is now a Non-Executive Director at Polarean.
MRI machines emit radiation and can only provide still images. The Polarisers strengthen the MRI signal by 100000 times which enables scanning down to the smallest of bronchioles which is just not possible with an MRI machine alone. Furthermore the Polariser will prevent the patient from becoming exposed to radiation.
Systems sale price - $475k
Profit margin on systems sale - $285k
Price paid to Polx per Xenon dose - $240
Profit per dose of Xenon - $170
Annual servicing contract - $40k
Profit on servicing - $20k
Software sales per annum - $50k
Profit on software $45000
For every 100 machines sold this will generate a recurring, yes every year profit of 12.7 million USD. Not to forget the 47.5 million USD in sales of the machines for every 100 sold.
These are my reasons for investing. These are the reasons why I will continue to hold well into the future.
I know. The recurring revenue streams from the xenon never mind machine sales & upgrades is astounding!
Sorry 23 mins 30
Hi Sacktheboard
If you are looking for financial potential Justin Waite's recent video covers it beautifully. Watch from 25 mins https://youtu.be/szqD0-9lXKw
You have made an excellent choice. I have been in this for a year and a half. The potential is absolutely astounding and we don't have that long to go now for approval.
Welcome Lee. I am sure I have seen you on the ODX board?
Numbers manufactured will more than make up for that Doctor. The diverse product range massively derisks this share and also the ability to adapt around demand. It is not all hedged on one product.
We heard Colin say before that ODX will adapt production to whatever is in demand. No matter who gets a massive order manufacturing will be required.
Yes it will. An astronomical amount of Antibody tests will be required.
I think the beauty of ODX is that any UK test that requires manufacturing on a mass scale would happily come knocking on the door should there be spare capacity.
Couldn't have happened to a nicer guy.
That is fair do's Pawnking. I respect those that do it honourably and do not go out trying to spook new investors.
One thing I have learned from the stock market is patience is rewarded. When I have tried to trade in the past I have lost out. Novacyte being one of them. We learn from our mistakes.
Totally agree TroyBoy. It seems to hit a new high one day retrace slightly then smash it the next day. Can't wait to hear if we are getting expedited review.
Well most of the waiting has been completed now so anyone who is in or considering coming in is in a good place. I understand how excited you are about the approval. I feel it too knowing that it is just around the corner.
So what if it is taking it's time pumpkin? Investors do not mind waiting for serious profits.
I have been in since April. I have never seen The Hat on the board before. Looks like one for the bin folks.